Genetic Testing for Familial Hypercholesterolemia in Clinical Practice

Curr Atheroscler Rep. 2023 May;25(5):197-208. doi: 10.1007/s11883-023-01094-2. Epub 2023 Apr 15.

Abstract

Purpose of review: Genetic testing has proven utility in identifying and diagnosing individuals with FH. Here we outline the current landscape of genetic testing for FH, recommendations for testing practices and the efforts underway to improve access, availability, and uptake.

Recent findings: Alternatives to the traditional genetic testing and counseling paradigm for FH are being explored including expanding screening programs, testing in primary care and/or cardiology clinics, leveraging electronic communication tools like chatbots, and implementing direct contact approaches to facilitate genetic testing of both probands and at-risk relatives. There is no consensus on if, when, and how genetic testing or accompanying genetic counseling should be provided for FH, though traditional genetic counseling and/or testing in specialty lipid clinics is often recommended in expert statements and professional guidelines. More evidence is needed to determine whether alternative approaches to the implementation of genetic testing for FH may be more effective.

Keywords: Familial hypercholesterolemia; Genetic counseling; Genetic testing.

Publication types

  • Review

MeSH terms

  • Genetic Testing*
  • Humans
  • Hyperlipoproteinemia Type II* / diagnosis
  • Hyperlipoproteinemia Type II* / genetics